West Coast Clinical Trials

WCCT Global launches special population recruitment tool

Tuesday, February 26, 2013 11:01 AM

WCCT Global, a CRO supporting phase I-IV biopharmaceutical and medical device development, has rolled out their special population Recruitment Management Tool (RMT) for early and late phase clinical studies.

More... »


WCCT Global successfully completes enrollment in ethnobridging study

Monday, February 11, 2013 02:37 PM

WCCT Global, a global CRO supporting phase I-IV bio-pharmaceutical and device development, announced the success of their specialized recruitment methods for ethnobridging studies.

More... »


WCCT Global, Verified Clinical Trials enhance clinical trials database registry

Monday, January 7, 2013 11:24 AM

WCCT Global, a full service CRO supporting phase I-IV development, has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the U.S., to help them enhance the capabilities of the VCT Clinical Trials Database Registry system.

More... »

WCCT names Affrime senior VP

Friday, September 9, 2011 01:21 PM

West Coast Clinical Trials has named Melton Affrime senior vice president, research and development, to further develop their growing clinical research capabilities.

More... »

Dedicated Phase I Appoints New CMO

Friday, June 26, 2009 10:54 AM

Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years' experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.

More... »

WCCT Names Vice President of Clinical Operations

Wednesday, September 24, 2008 04:29 PM

West Coast Clinical Trials (WCCT) appointed J. Jon Rojas vice president, clinical operations, for the Cypress, Calif.-based early stage CRO. Rojas will provide management oversight and strategic direction of the phase I business unit. Prior to joining WCCT, Rojas served as senior vice president of clinical services and support at OmniComm.

More... »


CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs